These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 7820985)

  • 1. [Telemestein and variations in blood concentrations of lipoprotein A].
    Gianotti A
    Clin Ter; 1994 Oct; 145(10):283-5. PubMed ID: 7820985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of storage of samples at -80 degrees C on the assay of lipoprotein(a) by rate nephelometry (Beckman 360 Array).
    Parent X; Ait Hmad Z; Aberer P
    Ann Biol Clin (Paris); 1995; 53(1-2):11-3. PubMed ID: 7574084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of endogenous and environmental factors on variations of serum lipoprotein (a) concentrations in a large population of insulin-treated diabetic patients.
    Durlach V; Gillery P; Bertin E; Grulet H; Gross A; Leutenegger M
    Diabetes Metab; 1998 Apr; 24(2):124-30. PubMed ID: 9592636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of serum lipoprotein(a) with the clinical presentation of Thai coronary artery disease patients.
    Leowattana W; Mahanonda N; Bhuripanyo K; Pokum S; Worawattananon P
    J Med Assoc Thai; 2000 Nov; 83 Suppl 2():S194-8. PubMed ID: 11194014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of aspirin on lipoprotein(a) in patients with ischemic stroke.
    Ranga GS; Kalra OP; Tandon H; Gambhir JK; Mehrotra G
    J Stroke Cerebrovasc Dis; 2007; 16(5):220-4. PubMed ID: 17845920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of elevated serum lipoprotein (a) concentrations on the risk of coronary heart disease in patients with type 2 diabetes mellitus.
    Murase T; Okubo M; Amemiya-Kudo M; Ebara T; Mori Y
    Metabolism; 2008 Jun; 57(6):791-5. PubMed ID: 18502261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lipoprotein(a) concentrations in type I diabetes mellitus].
    Figueroa AC; Gil RL; Pedragós AC; González GC; Marqués RB; Díaz JA; Llanos JO; Pérez AP
    Rev Clin Esp; 1996 Feb; 196(2):87-91. PubMed ID: 8685494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of a serum lipoprotein A-I immunoassay method].
    Shishino K; Hitsumoto Y; Osawa H; Makino H; Saheki S
    Rinsho Byori; 1999 Jun; 47(6):576-9. PubMed ID: 10434577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum lipopotein (a) levels in a large sample of subjects affected by familial combined hyperlipoproteinaemia and in general population.
    Cicero AF; Panourgia MP; Linarello S; D'Addato S; Sangiorgi Z; Gaddi A
    J Cardiovasc Risk; 2003 Apr; 10(2):149-51. PubMed ID: 12668913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low lipoprotein (a) levels during acute viral hepatitis.
    Geiss HC; Ritter MM; Richter WO; Schwandt P; Zachoval R
    Hepatology; 1996 Dec; 24(6):1334-7. PubMed ID: 8938156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High risk levels of lipoprotein(a) in Pakistani patients with type 2 diabetes mellitus.
    Habib SS; Aslam M
    Saudi Med J; 2003 Jun; 24(6):647-51. PubMed ID: 12847596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lipoprotein(a) concentrations and apolipoprotein(a) phenotype frequencies in cord blood of newborn infants and sera of children in Japan].
    Shimura Y; Tanaka T; Ohtani H
    Rinsho Byori; 1997 Mar; 45(3):255-9. PubMed ID: 9086832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein(a) concentrations in patients with type 2 diabetes mellitus without cardiovascular disease: relationship to metabolic parameters and diabetic complications.
    Tarkun I; Cetinarslan B; Cantürk Z
    Nutr Metab Cardiovasc Dis; 2002 Jun; 12(3):127-31. PubMed ID: 12325469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lp(a) concentrations in hyperapobetalipoproteinemia.
    Bairaktari E; Elisaf M
    Clin Chim Acta; 2001 Jan; 303(1-2):185. PubMed ID: 11270358
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of change of renal replacement therapy on serum lipoprotein (a) concentration.
    Misra M; Webb AT; Reaveley DA; Doherty E; O'Donnell M; Seed M; Brown EA
    Adv Perit Dial; 1997; 13():168-73. PubMed ID: 9360675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum lipoprotein (a) concentrations in a population of 819 non-insulin-dependent diabetic patients.
    Durlach V; Gillery P; Bertin E; Taupin JM; Grulet H; Gross A; Leutenegger M
    Diabetes Metab; 1996 Oct; 22(5):319-23. PubMed ID: 8896993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of Lp(a) plasma levels by bezafibrate.
    Maggi FM; Biasi GM; Catapano AL
    Atherosclerosis; 1993 Apr; 100(1):127-8. PubMed ID: 8318058
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum lipoprotein (a) levels in Behçet's disease.
    Seçkin D; Akpolat T; Oltulu Y; Erkan D; Cantürk T; Adam B; Turanli AY
    Br J Dermatol; 1995 Aug; 133(2):342-3. PubMed ID: 7547422
    [No Abstract]   [Full Text] [Related]  

  • 19. Triglyceride interference with an immunoturbidimetric quantification of lipoprotein(a) in serum.
    Panteghini M; Bonora R
    Clin Chem; 1994 Aug; 40(8):1601-3. PubMed ID: 8045011
    [No Abstract]   [Full Text] [Related]  

  • 20. Dyslipidaemia: Early-phase trials of lipoprotein(a) lowering.
    Lim GB
    Nat Rev Cardiol; 2016 Dec; 13(12):696. PubMed ID: 27734970
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.